Hemodynamic overload of the left ventricle results in LV remodeling with the development of myocardial hypertrophy that often progresses to failure. In patients with heart failure there is increased oxidative stress suggesting that reactive oxygen species (ROS) may be involved. Using an in vitro system of cyclic mechanical strain that simulates the higher wall stress that occurs with hemodynamic overload, I have shown ROS plays a critical role in mediating two key features of myocardial remodeling-myocyte growth and apoptosis. The ROS that mediate these effects of mechanical strain on cardiocyte phenotype is unknown. Several lines of evidence suggest that hydrogen peroxide (H2O2) plays a central role. First, my preliminary data obtained by overexpressing superoxide dismutase and catalase in cardiac myocytes in vitro suggests that H2O2, not superoxide, mediates both myocyte growth and apoptosis. Second, other data confirm that direct application of H2O2 can cause both growth and apoptosis of cardiac myocytes in vitro. Finally, higher levels of hydroxyl radical (.OH), a breakdown product of H2O2, have been demonstrated in failing heart. Thus, my primary hypothesis is that H2O2 plays a major role in mediating myocardial remodeling due to hemodynamic overload. The goals of this project are: 1) to define the role of hydrogen peroxide in mechanical stretch-induced myocyte growth and apoptosis; 2) to determine the signaling kinases that are activated by hydrogen peroxide and the direct redox modifications that occur with these; 3) to utilize in vivo mouse models of site directed mitochondrial catalase to evaluate the short and chronic effects of pressure overload and the benefits of antioxidants; and 4) the use of proteomics to evaluate the direct protein modifications that may regulate protein function.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL071563-02
Application #
7127677
Study Section
Special Emphasis Panel (ZHL1-CSR-M (O1))
Program Officer
Varghese, Jamie
Project Start
2005-09-30
Project End
2010-07-31
Budget Start
2006-09-01
Budget End
2007-07-31
Support Year
2
Fiscal Year
2006
Total Cost
$126,792
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Bachschmid, Markus M; Schildknecht, Stefan; Matsui, Reiko et al. (2013) Vascular aging: chronic oxidative stress and impairment of redox signaling-consequences for vascular homeostasis and disease. Ann Med 45:17-36
Pimentel, David; Haeussler, Dagmar Johanna; Matsui, Reiko et al. (2012) Regulation of cell physiology and pathology by protein S-glutathionylation: lessons learned from the cardiovascular system. Antioxid Redox Signal 16:524-42
Haeussler, Dagmar J; Evangelista, Alicia M; Burgoyne, Joseph R et al. (2011) Checkpoints in adenoviral production: cross-contamination and E1A. PLoS One 6:e23160
Kienhöfer, Joachim; Häussler, Dagmar Johanna Franziska; Ruckelshausen, Florian et al. (2009) Association of mitochondrial antioxidant enzymes with mitochondrial DNA as integral nucleoid constituents. FASEB J 23:2034-44
Oshima, Yuichi; Ouchi, Noriyuki; Shimano, Masayuki et al. (2009) Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury. Circulation 120:1606-15
Oshima, Yuichi; Ouchi, Noriyuki; Sato, Kaori et al. (2008) Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation 117:3099-108